Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 38 citing Sun: A selective aldose reductase inhibitor of a new structural class prevents or reverses.... (0.11 sec) 

[PDF] Contributions of inflammatory processes to the development of the early stages of …


TS Kern - Exp Diabetes Res, 2007 - hindawi.com
Diabetes causes metabolic and physiologic abnormalities in the retina, and these changes suggest
a role for inflammation in the development of diabetic retinopathy. These changes include upregulation
of iNOS, COX-2, ICAM-1, caspase 1, VEGF, and NF-κB, increased production of nitric ...
Cited by 34 - Related articles - View as HTML - All 12 versions

Lower somatostatin expression is an early event in diabetic retinopathy and is …

- diabetesjournals.org
E Carrasco, C Hernández, A Miralles, P Huguet, J … - Diabetes Care, 2007 - Am Diabetes Assoc
RESULTS—A higher expression of SST was detected in RPE than neuroretina in both
groups. SST mRNA levels and SST-28 immunoreactivity were significantly lower in both RPE
and the neuroretina from diabetic donors compared with nondiabetic donors. These ...
Cited by 11 - Related articles - BL Direct - All 4 versions

[PDF] The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, …


M Lorenzi - Exp Diabetes Res, 2007 - hindawi.com
The polyol pathway is a two-step metabolic pathway in which glucose is reduced to sorbitol,
which is then converted to fructose. It is one of the most attractive candidate mechanisms to
explain, at least in part, the cellular toxicity of diabetic hyperglycemia because (i) it ...
Cited by 9 - Related articles - View as HTML - All 15 versions

Aldose reductase inhibitor fidarestat counteracts diabetes-associated cataract …


VR DREL, PAL PACHER, TK ALI, J SHIN, … - … journal of molecular …, 2008 - pubmedcentral.nih.gov
This study was aimed at evaluating the potent and specific aldose reductase inhibitor
fidarestat, on diabetes-associated cataract formation, and retinal oxidative-nitrosative stress,
glial activation, and apoptosis. Control and streptozotocin-diabetic rats were treated with ...
Cited by 9 - Related articles - BL Direct - All 3 versions

[PDF] Cellular signaling and potential new treatment targets in diabetic retinopathy


ZA Khan, S Chakrabarti - Exp Diabetes Res, 2007 - hindawi.com
Dysfunction and death of microvascular cells and imbalance between the production and the
degradation of extracellular matrix (ECM) proteins are a characteristic feature of diabetic retinopathy
(DR). Glucose-induced biochemical alterations in the vascu- lar endothelial cells may ...
Cited by 8 - Related articles - View as HTML - All 15 versions

Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and …


SA Madsen-Bouterse, RA Kowluru - Reviews in Endocrine & Metabolic …, 2008 - Springer
Abstract Retinopathy is one of the most severe ocular complications of diabetes and is a leading
cause of acquired blindness in young adults. The cellular components of the retina are highly
coordinated but very susceptible to the hyperglycemic environment. The microvasculature ...
Cited by 6 - Related articles - All 2 versions

AGE and RAGE inhibitors in the treatment of diabetic retinopathy


A Bhatwadekar, AW Stitt - Expert Review of Ophthalmology, 2007 - ingentaconnect.com
Diabetic retinopathy is a major complication of diabetes and several biochemical/molecular mechanisms
have been proposed as key instigators in the initiation and progression of the condition. Accumulating
evidence suggests that formation of advanced glycation end products (AGEs) within the ...
Cited by 4 - Related articles - BL Direct - All 3 versions

Update on the treatment of diabetic retinopathy.


JL Wilkinson-Berka, AG Miller - TheScientificWorldJOURNAL, 2008 - thescientificworld.com
Review Article TheScientificWorldJOURNAL (2008) 8, 98–120 ISSN 1537-744X; DOI
10.1100/tsw.2008.25 ... *Corresponding author. ©2008 with author. Published by
TheScientificWorld; www.thescientificworld.com ... Jennifer L. Wilkinson-Berka* and ...
Cited by 4 - Related articles - All 2 versions

Upregulation of aldose reductase during foam cell formation as possible link …

- ahajournals.org [PDF] 
CA Gleissner, JM Sanders, J Nadler, K … - … , thrombosis, and vascular …, 2008 - Am Heart Assoc
Kluwer Health, 351 West Camden Street, Baltimore, MD 21202-2436. Phone:
410-528-4050. Permissions: Permissions & Rights Desk, Lippincott Williams & Wilkins, a division
of Wolters ... Upregulation of Aldose Reductase During Foam Cell
Cited by 5 - Related articles - All 7 versions

Flavonoids as inhibitors of human carbonyl reductase 1


M Carlquist, T Frejd, MF Gorwa-Grauslund - Chemico-Biological Interactions, 2008 - Elsevier
Human carbonyl reductase 1 (CBR1), that is one of the enzymes responsible for the reduced
efficiency of treatments by the antineoplastic agents anthracyclines, was functionally expressed
in Saccharomyces cerevisiae. CBR1 was purified and kinetically characterised using ...
Cited by 2 - Related articles - All 3 versions


Result Page: 

1

2

3

4

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google